Related Experiment Video
Updated: May 16, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
Published on: March 8, 2019
Catecholamines can induce pulmonary remodeling in rats.
Beate Rassler1, Grit Marx, Katrin Schierle
1Carl-Ludwig-Institute of Physiology, University of Leipzig, Leipzig, Germany. Beate.Rassler@medizin.uni-leipzig.de
Catecholamine infusion in rats causes pulmonary remodeling, with both alpha- and beta-adrenergic mechanisms contributing to extracellular matrix changes. Cardiac hypertrophy is primarily a beta-adrenergic effect.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Research
- Pharmacology
Background:
- Catecholamine (CA) infusion in rats previously induced pulmonary injury, edema, and inflammation.
- This study investigates CA effects on pulmonary extracellular matrix remodeling.
Purpose of the Study:
- To examine the effects of norepinephrine (NE) and selective alpha- and beta-adrenergic agonists on pulmonary extracellular matrix remodeling.
- To understand the mechanisms underlying catecholamine-induced lung injury and remodeling.
Main Methods:
- Rats were infused with NE, phenylephrine (PE), isoproterenol (ISO), or saline for 8-72 hours.
- Assessed mRNA expression of collagen, MMP-2, TIMP-2, and TGF-β isoforms in lung tissue.
- Evaluated lung histology, hemodynamic function, and cardiac hypertrophy.
Main Results:
- 72-hour infusion led to pulmonary fibrosis and vascular hypertrophy.
- Elevated mRNA expression of collagen type I, MMP-2, and TIMP-2, most pronounced with NE.
- TGF-β mRNA increased, particularly after PE; cardiac hypertrophy was most pronounced after ISO.
Conclusions:
- Catecholamine infusion over 72 hours induces pulmonary remodeling via alpha- and beta-adrenergic mechanisms.
- Cardiac hypertrophy is mainly mediated by beta-adrenergic stimulation, suggesting a direct adrenergic effect.
- Pulmonary remodeling is distinct from, and not a direct consequence of, catecholamine-induced cardiac hypertrophy.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...

